Chang EM, Saigal CS, Raldow AC. Explaining health state utility assessment. JAMA. 2020;323(11):1085–6.

Article  PubMed  Google Scholar 

Wolowacz SE, Briggs A, Belozeroff V, Clarke P, Doward L, Goeree R, et al. Estimating health-state utility for economic models in clinical studies: an ISPOR Good Research Practices Task Force report. Value Health. 2016;19(6):704–19.

Article  PubMed  Google Scholar 

Payakachat N, Murawski MM, Summers KH. Health utility and economic analysis: theoretical and practical issues. Expert Rev Pharmacoecon Outcomes Res. 2009;9(4):289–92.

Article  PubMed  Google Scholar 

Whitehead SJ, Ali S. Health outcomes in economic evaluation: the QALY and utilities. Br Med Bull. 2010;96:5–1.

Article  PubMed  Google Scholar 

Muchadeyi MT, Hernandez-Villafuerte K, Schlander M. Quality appraisal for systematic literature reviews of health state utility values: a descriptive analysis. BMC Med Res Methodol. 2022;22(1):303.

Article  PubMed  PubMed Central  Google Scholar 

Zoratti MJ, Pickard AS, Stalmeier PFM, Ollendorf D, Lloyd A, Chan KKW, et al. Evaluating the conduct and application of health utility studies: a review of critical appraisal tools and reporting checklists. Eur J Health Econ. 2021;22(5):723–33.

Article  PubMed  Google Scholar 

Longworth L, Rowen D. NICE DSU Technical Support Document 10: The Use of Mapping Methods to Estimate Health State Utility Values [Internet]. London: National Institute for Health and Care Excellence (NICE); 2011. PMID: 28481491.

Petrou S, Kwon J, Madan J. A practical guide to conducting a systematic review and meta-analysis of health state utility values. Pharmacoeconomics. 2018;36(9):1043–61.

Article  PubMed  Google Scholar 

Xie F, Zoratti M, Chan K, Husereau D, Krahn M, Levine O, et al. Toward a centralized, systematic approach to the identification, appraisal, and use of health state utility values for reimbursement decision making: introducing the Health Utility Book (HUB). Med Decis Mak. 2019;39(4):370–8.

Article  Google Scholar 

Ara R, Brazier J, Peasgood T, Paisley S. The identification, review and synthesis of health state utility values from the literature. Pharmacoeconomics. 2017;35(Suppl. 1):43–55.

Article  PubMed  Google Scholar 

Ara R, Hill H, Lloyd A, Woods HB, Brazier J. Are current reporting standards used to describe health state utilities in cost-effectiveness models satisfactory? Value Health. 2020;23(3):397–405.

Article  PubMed  Google Scholar 

Ara R, Peasgood T, Mukuria C, Chevrou-Severac H, Rowen D, Azzabi-Zouraq I, et al. Sourcing and using appropriate health state utility values in economic models in health care. Pharmacoeconomics. 2017;35(Suppl. 1):7–9.

Article  PubMed  Google Scholar 

Sanderson S, Tatt ID, Higgins JP. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int J Epidemiol. 2007;36(3):666–76.

Article  PubMed  Google Scholar 

Yepes-Nuñez JJ, Zhang Y, Xie F, Alonso-Coello P, Selva A, Schünemann H, et al. Forty-two systematic reviews generated 23 items for assessing the risk of bias in values and preferences’ studies. J Clin Epidemiol. 2017;85:21–31.

Article  PubMed  Google Scholar 

Büttner F, Winters M, Delahunt E, Elbers R, Lura CB, Khan KM, et al. Identifying the ’incredible’! Part 1: assessing the risk of bias in outcomes included in systematic reviews. Br J Sports Med. 2020;54(13):798–800.

Article  PubMed  Google Scholar 

Büttner F, Winters M, Delahunt E, Elbers R, Lura CB, Khan KM, et al. Identifying the ’incredible’! Part 2: spot the difference: a rigorous risk of bias assessment can alter the main findings of a systematic review. Br J Sports Med. 2020;54(13):801–8.

Article  PubMed  Google Scholar 

Katikireddi SV, Egan M, Petticrew M. How do systematic reviews incorporate risk of bias assessments into the synthesis of evidence? A methodological study. J Epidemiol Commun Health. 2015;69(2):189–95.

Article  Google Scholar 

Marušić MF, Fidahić M, Cepeha CM, Farcaș LG, Tseke A, Puljak L. Methodological tools and sensitivity analysis for assessing quality or risk of bias used in systematic reviews published in the high-impact anesthesiology journals. BMC Med Res Methodol. 2020;20(1):121.

Article  PubMed  PubMed Central  Google Scholar 

Walker DG, Wilson RF, Sharma R, Bridges J, Niessen L, Bass EB, et al. AHRQ methods for effective health care. Best practices for conducting economic evaluations in health care: a systematic review of quality assessment tools. Rockville: Agency for Healthcare Research and Quality (US); 2012.

Afshari S, Ameri H, Daroudi RA, Shiravani M, Karami H, Akbari SA. Health related quality of life in adults with asthma: a systematic review to identify the values of EQ-5D-5L instrument. J Asthma. 2022;59(6):1203–12.

Article  PubMed  Google Scholar 

Brennan VK, Mauskopf J, Colosia AD, Copley-Merriman C, Hass B, Palencia R. Utility estimates for patients with type 2 diabetes mellitus after experiencing a myocardial infarction or stroke: a systematic review. Expert Rev Pharmacoecon Outcomes Res. 2015;15(1):111–23.

Article  PubMed  Google Scholar 

Buchanan-Hughes AM, Buti M, Hanman K, Langford B, Wright M, Eddowes LA. Health state utility values measured using the EuroQol 5-dimensions questionnaire in adults with chronic hepatitis C: a systematic literature review and meta-analysis. Qual Life Res. 2019;28(2):297–319.

Article  CAS  PubMed  Google Scholar 

Carrello J, Hayes A, Killedar A, Von Huben A, Baur LA, Petrou S, et al. Utility decrements associated with adult overweight and obesity in Australia: a systematic review and meta-analysis. Pharmacoeconomics. 2021;39(5):503–19.

Article  PubMed  Google Scholar 

Carter GC, King DT, Hess LM, Mitchell SA, Taipale KL, Kiiskinen U, et al. Health state utility values associated with advanced gastric, oesophageal, or gastro-oesophageal junction adenocarcinoma: a systematic review. J Med Econ. 2015;18(11):954–66.

Article  PubMed  Google Scholar 

Di Tanna GL, Urbich M, Wirtz HS, Potrata B, Heisen M, Bennison C, et al. Health state utilities of patients with heart failure: a systematic literature review. Pharmacoeconomics. 2021;39(2):211–29.

Article  PubMed  Google Scholar 

Gheorghe A, Moran G, Duffy H, Roberts T, Pinkney T, Calvert M. Health utility values associated with surgical site infection: a systematic review. Value Health. 2015;18(8):1126–37.

Article  PubMed  Google Scholar 

Han R, François C, Toumi M. Systematic review of health state utility values used in European pharmacoeconomic evaluations for chronic hepatitis C: impact on cost-effectiveness results. Appl Health Econ Health Policy. 2021;19(1):29–44.

Article  PubMed  Google Scholar 

Kua WS, Davis S. PRS49: systematic review of health state utilities in children with asthma. Value Health. 2016;19(7):A557.

Article  Google Scholar 

Li L, Severens JLH, Mandrik O. Disutility associated with cancer screening programs: a systematic review. PLoS ONE. 2019;14(7): e0220148.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Paracha N, Abdulla A, MacGilchrist KS. Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients. Health Qual Life Outcomes. 2018;16(1):179.

Article  PubMed  PubMed Central  Google Scholar 

Park HY, Cheon HB, Choi SH, Kwon JW. Health-related quality of life based on EQ-5D utility score in patients with tuberculosis: a systematic review. Front Pharmacol. 2021;12: 659675.

Article  PubMed  PubMed Central  Google Scholar 

Petrou S, Krabuanrat N, Khan K. Preference-based health-related quality of life outcomes associated with preterm birth: a systematic review and meta-analysis. Pharmacoeconomics. 2020;38(4):357–73.

Article  PubMed  Google Scholar 

Saeed YA, Phoon A, Bielecki JM, Mitsakakis N, Bremner KE, Abrahamyan L, et al. A systematic review and meta-analysis of health utilities in patients with chronic hepatitis C. Value Health. 2020;23(1):127–37.

Article  PubMed  Google Scholar 

Szabo SM, Audhya IF, Malone DC, Feeny D, Gooch KL. Characterizing health state utilities associated with Duchenne muscular dystrophy: a systematic review. Qual Life Res. 2020;29(3):593–605.

Article  PubMed  Google Scholar 

Van Wilder L, Rammant E, Clays E, Devleesschauwer B, Pauwels N, De Smedt D. A comprehensive catalogue of EQ-5D scores in chronic disease: results of a systematic review. Qual Life Res. 2019;28(12):3153–61.

Article  PubMed  Google Scholar 

Ward Fuller G, Hernandez M, Pallot D, Lecky F, Stevenson M, Gabbe B. Health state preference weights for the Glasgow Outcome Scale following traumatic brain injury: a systematic review and mapping study. Value Health. 2017;20(1):141–51.

Article  PubMed  PubMed Central  Google Scholar 

Yuan Y, Xiao Y, Chen X, Li J, Shen M. A systematic review and meta-analysis of health utility estimates in chronic spontaneous urticaria. Front Med (Lausanne). 2020;7: 543290.

Article  PubMed  PubMed Central  Google Scholar 

Blom EF, Haaf KT, de Koning HJ. Systematic review and meta-analysis of community- and choice-based health state utility values for lung cancer. Pharmacoeconomics. 2020;38(11):1187–200.

Article  PubMed  PubMed Central  Google Scholar 

Foster E, Chen Z, Ofori-Asenso R, Norman R, Carney P, O’Brien TJ, et al. Comparisons of direct and indirect utilities in adult epilepsy populations: a systematic review. Epilepsia. 2019;60(12):2466–76.

Article  PubMed  Google Scholar 

Haridoss M, Bagepally BS, Natarajan M. Health-related quality of life in rheumatoid arthritis: systematic review and meta-analysis of EuroQoL (EQ-5D) utility scores from Asia. Int J Rheum Dis. 2021;24(3):314–26.

Article  PubMed  Google Scholar